Valuation: Teva Pharmaceutical Industries Limited

Market Cap 40.12B 0 34.84B 32.48B 29.84B 56.43B 3,816B 57.05B 383B 150B 1,908B 151B 147B 6,321B P/E 2026 *
46.2x
P/E 2027 * 18.9x
Enterprise Value 52B 0 45.15B 42.1B 38.67B 73.14B 4,946B 73.94B 496B 194B 2,473B 195B 191B 8,193B EV / Sales 2026 *
3.14x
EV / Sales 2027 * 2.82x
Free-Float
88.61%
Yield 2026 *
-
Yield 2027 * -
1 day-0.77%
1 week+7.98%
Current month-4.78%
1 month-1.24%
3 months-1.43%
6 months-8.33%
Current year+2.58%
1 week 10,300
Extreme 10300
10,970
1 month 9,396
Extreme 9396
10,970
Current year 8,860
Extreme 8860
11,350
1 year 5,434
Extreme 5434
11,350
3 years 3,250
Extreme 3250
11,350
5 years 2,383
Extreme 2383
11,350
10 years 2,175
Extreme 2175
20,860
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2023
Director of Finance/CFO 53 22/12/2019
Chief Operating Officer 52 03/06/2024
Director TitleAgeSince
Director/Board Member 69 01/01/2009
Chairman 78 06/02/2017
Director/Board Member 65 01/09/2015
Change 5-day change 1-year change 3-year change Capi.($)
-0.77%+7.98% - - 40.12B
-0.51%-8.60%+45.08%+148.21% 995B
+0.20%-4.42%+49.05%+50.81% 614B
-0.53%-7.37%+23.64%+65.03% 431B
+0.48%-2.77%+40.27%+34.96% 353B
+0.08%-4.45%+31.74%+39.89% 293B
+2.09%-9.27%+5.42%+7.61% 245B
+1.75%-8.29%-1.73%-42.05% 210B
+2.94%-0.78%+29.17%+60.32% 210B
+3.13%+0.69%+18.11%+71.90% 168B
Average +0.98%-4.74%+26.75%+48.52% 390.92B
Weighted average by Cap. +0.72%-5.66%+33.77%+70.63%

Financials

2026 *2027 *
Net sales 16.58B 0 14.4B 13.42B 12.33B 23.32B 1,577B 23.58B 158B 61.87B 788B 62.27B 60.91B 2,613B 17.3B 0 15.03B 14.01B 12.87B 24.34B 1,646B 24.61B 165B 64.57B 823B 64.98B 63.56B 2,726B
Net income 1.14B 0 990M 923M 848M 1.6B 108B 1.62B 10.88B 4.26B 54.23B 4.28B 4.19B 180B 2.34B 0 2.03B 1.89B 1.74B 3.29B 222B 3.32B 22.3B 8.72B 111B 8.78B 8.58B 368B
Net Debt 11.88B 0 10.31B 9.62B 8.83B 16.71B 1,130B 16.89B 113B 44.32B 565B 44.6B 43.63B 1,871B 8.61B 0 7.48B 6.97B 6.4B 12.11B 819B 12.24B 82.19B 32.13B 409B 32.34B 31.63B 1,357B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
04/08/26 ILA 10,350.00 -0.77% 756,460
03/08/26 ILA 10,430.00 -4.05% 936,895
31/07/26 ILA 10,870.00 +1.78% 672,031
30/07/26 ILA 10,680.00 +1.14% 1,803,433
29/07/26 ILA 10,560.00 +10.17% 2,354,552
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
34.43USD
Average target price
41.20USD
Spread / Average Target
+19.66%

Quarterly revenue - Rate of surprise